Sunday 09 Mar, 2025 08:15 PM
Site map | Locate Us | Login
   UltraTech Cement retains top credit ratings from CARE Ratings    HFCL arm bags supply contract from Indian Army    Tata Power arm signs MoU with Andhra Pradesh Govt to develop RE projects    RailTel Corporation bags work order from Northern Railway worth Rs 28 crore    Alembic Pharma's Vadodara facility gets one Form 483 observation from US FDA    Shilpa Medicare's Raichur units gets Form 483 with one observation from US FDA    JSW Steel's crude steel production climbs 12% YoY in February 2025    Oriental Rail Infra secures Rs 43-cr Vande Bharat order from Indian Railways    Lemon Tree Hotels signs two new properties in Madhya Pradesh    Laxmi Dental spurts 33% in four days    Quess Corp jumps on NCLT approval for three-way demerger    Gensol Engineering Ltd leads losers in 'A' group    Shaily Engg jumps 20% in six days    Nagarjuna Fertilizers & Chemicals Ltd leads losers in 'B' group    B R Goyal Infra bags Rs 71-cr work order from NHAI 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Alembic Pharma's Vadodara facility gets one Form 483 observation from US FDA
08-Mar-25   12:53 Hrs IST

Post the conclusion of this scheduled inspection, the US FDA issued a Form 483 with one procedural observation the company's aforementioned unit.

'The company will provide comprehensive response to US FDA for the observations within the stipulated period,' Alembic Pharmaceuticals said in a statement.

The announcement was made after market hours on Friday.

Alembic Pharmaceuticals is in the business of the development, manufacturing, and marketing of pharmaceutical products, i.e., formulations and active pharmaceutical ingredients.

The company's consolidated net profit tumbled 23.29% to Rs 138.42 crore in Q3 FY25, compared with Rs 180.45 crore posted in Q3 FY24. Revenue from operations was at Rs 1,692.74 crore in the third quarter of FY25, up 3.81% year on year (YoY).

The scrip had jumped 4.26% to end at Rs 845.65 on the BSE on Friday.

Powered by Capital Market - Live News
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Account Closure | RE-KYC | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures | |Rights & Obligations-English| Rights & Obligations-தமிழ் | Anti Money Laundering Policy | E-Voting | CSR | Voluntary Freezing / Blocking Hit Count : 39392751
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd